-
1
المؤلفون: Henning Wege, Bernhard Scheiner, Fredrik Waneck, Philipp Schwabl, Fabian Finkelmeier, Matthias Pinter, F. Hucke, Jörg Trojan, Thomas Reiberger, Arndt Vogel, Sandra Koch, Kornelius Schulze, Michael Trauner, Markus Peck-Radosavljevic, Oliver Waidmann, Wolfgang Sieghart, Jan B. Hinrichs, Arndt Weinmann, Christian Müller, Martha M. Kirstein, Johann von Felden
المصدر: Alimentary Pharmacology & Therapeutics. 49:1323-1333
مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Programmed cell death, Carcinoma, Hepatocellular, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Antibodies, Monoclonal, Humanized, Targeted immunotherapy, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Germany, Internal medicine, Carcinoma, medicine, Humans, Pharmacology (medical), 030212 general & internal medicine, Aged, Retrospective Studies, Hepatology, business.industry, Liver Neoplasms, Gastroenterology, Retrospective cohort study, Immunotherapy, Middle Aged, medicine.disease, Nivolumab, Austria, Hepatocellular carcinoma, Monoclonal, Cohort, Female, 030211 gastroenterology & hepatology, business
-
2
المؤلفون: Rudolf E. Stauber, Janett Fischer, Marsha Y. Morgan, Thomas Berg, Andrew McQuillin, Waleed Fateen, Jane I. Grove, Marcin Krawczyk, Stephan Buch, Astrid Marot, Hans Dieter Nischalke, Christian Datz, Ali Canbay, Henning Wege, Markus Casper, Jonel Trebicka, Pierre Deltenre, Jens U. Marquardt, Alexander Link, Ulrich Spengler, Ines Silva, Philipp Lutz, Daniel Gotthardt, Carolin Lackner, Andre Franke, Karl Heinz Weiss, Guruprasad P. Aithal, Felix Stickel, Jean-François Dufour, Mona Elamly, Jochen Hampe, Thomas W.M. Buckley, Laurent Spahr, Johann von Felden, Florian Eyer, S Nehring, V Moser, Steffen Zopf, Jonas Rosendahl, Stephen R. Atkinson, Silke Marhenke, Arndt Vogel, Sebastian Mueller, Luca Valenti, Clemens Schafmayer, Frank Lammert, Vanessa Rausch, Rohini Sharma
المساهمون: UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Service de gastro-entérologie
المصدر: Hepatology, Vol. 72, no. 1, p. 88-102 (2020)
Stickel, Felix; Lutz, Philipp; Buch, Stephan; Nischalke, Hans Dieter; Silva, Ines; Rausch, Vanessa; Fischer, Janett; Weiss, Karl Heinz; Gotthardt, Daniel; Rosendahl, Jonas; Marot, Astrid; Elamly, Mona; Krawczyk, Marcin; Casper, Markus; Lammert, Frank; Buckley, Thomas Wm; McQuillin, Andrew; Spengler, Ulrich; Eyer, Florian; Vogel, Arndt; ... (2020). Genetic variation in HSD17B13 reduces the risk of developing cirrhosis and hepatocellular carcinoma in alcohol misusers. Hepatology, 72(1), pp. 88-102. Wiley 10.1002/hep.30996 <http://dx.doi.org/10.1002/hep.30996>مصطلحات موضوعية: 0301 basic medicine, Male, Cirrhosis, 17-Hydroxysteroid Dehydrogenases, VARIANT, PROGRESSION, Gastroenterology, Cohort Studies, Liver disease, 0302 clinical medicine, SNP RS738409G ALLELE, DEPENDENCE, Liver Cirrhosis, Alcoholic, 600 Technology, 610 Medicine & health, Aged, 80 and over, education.field_of_study, Framingham Risk Score, Liver Neoplasms, ASSOCIATION, lipotoxicity, Middle Aged, Alcoholism, 1101 Medical Biochemistry and Metabolomics, 1107 Immunology, Hepatocellular carcinoma, adiponutrin, 030211 gastroenterology & hepatology, Female, candidate genes, Life Sciences & Biomedicine, medicine.medical_specialty, Carcinoma, Hepatocellular, Population, Lower risk, Risk Assessment, 03 medical and health sciences, LIVER-DISEASE, Internal medicine, medicine, genetic risk association, Humans, Adiponutrin, education, PNPLA3, METAANALYSIS, Aged, DISEASE-ASSOCIATED MORTALITY, Science & Technology, Hepatology, Gastroenterology & Hepatology, business.industry, fibrosis, Genetic Variation, 1103 Clinical Sciences, Odds ratio, medicine.disease, 030104 developmental biology, host genetics, business, genetic susceptibility
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a07cb501fd90a99567234ae51aa0d596
https://hdl.handle.net/2078.1/230750